Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis
Introduction
The olfactory system shares common origins with the central nervous system, and its development is strongly genetically determined (Treloar et al., 2010). Hence, the system has become a subject of interest in studies on the pathogenesis of schizophrenia, which itself is considered a neurodevelopmental disorder with genetic determinants (Murray, 1994). The presence of olfactory impairment in schizophrenia has been widely documented, with an effect size estimated as medium to large (Moberg et al., 1999, Moberg et al., 2014, Turetsky et al., 2009). This impairment manifests itself as a wide variety of abnormalities, including impairments in odor detection threshold (Isseroff et al., 1987, Rupp et al., 2005a, Serby et al., 1990), odor identification (Brewer et al., 2001, Hurwitz et al., 1988, Houlihan et al., 1994, Kamath et al., 2014, Kästner et al., 2013, Kopala et al., 1993) and odor discrimination abilities (Rupp et al., 2005a), as well as odor memory (Campbell and Gregson, 1972, Wu et al., 1993). There is also a growing body of evidence suggesting that the hedonic judgment of smells is also impaired in schizophrenia, with various patterns of misassignment being attributed to the hedonic valence of odors (Crespo-Facorro et al., 2001, Doop and Park, 2006, Hudry et al., 2002, Kamath et al., 2011a, Kamath et al., 2011b, Kamath et al., 2013b, Moberg et al., 2003, Plailly et al., 2006, Rupp et al., 2005b). Neuroanatomical, cellular and even intracellular mechanisms have been recognized to play a role in olfactory deficits in schizophrenia (Borgmann-Winter et al., 2016, Egbujo et al., 2015; for a review see Turetsky et al., 2009).
Some studies report the presence of olfactory identification deficits (OIDs) in non-affected first-degree relatives of patients with schizophrenia, including monozygotic twins discordant for the illness (Kamath et al., 2014, Kopala et al., 1998, Kopala et al., 2001, Roalf et al., 2006, Turetsky et al., 2008). Results from both the clinical and biological domains suggest that OIDs may be a potential vulnerability marker of schizophrenia (Moberg et al., 2014, Turetsky et al., 2008).
In the case of schizophrenia, clinical signs of abnormal functioning are present long before the development of the frank psychosis (Jones et al., 1994). It can therefore be assumed that other manifestations of neurodevelopmental pathology should be present in early phases of the disease, including prodromal ones. Over the years, the concept of the prodrome (Mayer-Gross, 1932) has evolved into that of the ultra-high risk-UHR or at-risk mental state-ARMS (Yung and McGorry, 1996). While the predictive value of ARMS is relatively low when defined based solely on clinical symptoms, with the conversion rate reaching approximately 36% within a three-year follow-up period (Fusar-Poli et al., 2012), the validity of the ARMS concept could be improved with the inclusion of complementary tools addressing, inter alia, neurobiological features (Fusar-Poli et al., 2013, Modinos and McGuire, 2015). One encouraging tool, potentially allowing the evaluation of further risk of transition from ARMS to psychosis, could be the assessment of smell identification ability. Although only few studies regarding olfactory impairment have been performed in clinical high risk for psychosis (CHR) cohorts, some indicate that olfactory deficits are in fact, more common in “at-risk” individuals than healthy controls (Kamath et al., 2014, Woodberry et al., 2010). The results, however, are conflicting, and the findings regarding OID and the future transition of ARMS to psychosis are inconsistent (Brewer et al., 2003, Gill et al., 2014, Lin et al., 2015).
Only one study has attempted to determine the effect of odor hedonic valence on olfactory identification (OI) in CHR individuals; in this case, the hedonic valence of an odor was found to have a significant effect on identification accuracy (Kamath et al., 2013b). No follow-up for transition of CHR state to psychosis was performed in this study. Hence, it is accepted within the field that further studies of olfactory dysfunctions are required in CHR individuals (Moberg et al., 2014, Turetsky et al., 2012). No study has yet investigated the associations between the identification of odors from different hedonic categories and the transition to psychotic disorders.
The objective of the present study was to identify the relationship between general smell identification ability as well as OI performance, according to the hedonic attributes of the odors, and the risk of conversion to psychosis in a cohort of ARMS individuals.
Section snippets
Settings and subjects
Eighty-one individuals aged 15–32 years meeting the criteria of an ARMS were included in the study. All were recruited from the 105 participants of the Programme of Recognition and Therapy (PORT), which is a programme affiliated with the Medical University of Łódź, Poland, intended for young people at risk of developing a psychotic disorder. The PORT programme is described in detail elsewhere (Kotlicka-Antczak et al., 2015).
The following exclusion criteria were used: 1) the presence of a known
Demographic, clinical and outcome characteristics
Baseline socio-demographic and clinical characteristics of the ARMS group are presented in Table 1. Participants were followed up for a median time of 33 months (25th–75th percentile: 9–62 months; mean time: 36.1 ± 27.5 months). The overall transition rate was 24.7%. All “converters” developed schizophrenia.
Nineteen of the 20 transitions (95%) into psychosis in the sample occurred within the first 24 months, which is in line with previous studies in the field (Fusar-Poli et al., 2012, Fusar-Poli et
Discussion
This is the first study to address the associations between OI ability based on the hedonic valence of the odor and the transition of an ARMS into psychotic disorder. Our findings indicate that ARMS individuals who converted to psychosis present a significantly impaired ability to identify normatively-defined pleasant odors compared to ARMS individuals who did not transition. No differences for neutral or unpleasant odors were observed. Deficits in the identification of pleasant odors appeared
Authors' contributions
Magdalena Kotlicka-Antczak and Małgorzata Urban-Kowalczyk designed the study. Magdalena Kotlicka-Antczak, Michał Seweryn Karbownik and Małgorzata Urban-Kowalczyk wrote the manuscript. Magdalena Kotlicka-Antczak, Agnieszka Pawełczyk, Tomasz Pawełczyk and Natalia Żurner were in charge of subject recruitment and data collection as well as of performing clinical evaluations of the participants. Michał Seweryn Karbownik performed statistical analysis of the data. Magdalena Kotlicka-Antczak, Tomasz
Conflicts of interest
All authors declare no conflicts of interest for the present study.
Role of the funding source
This work was supported by the Polish Science National Centre (grant number NN 402 1793 34).
Acknowledgements
This work was supported by the Polish Science National Centre (grant number NN 402 1793 34).
We would like to thank all the psychiatrists referring participants to the study.
References (65)
- et al.
Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis
Biol. Psychiatry
(2012) - et al.
Prediction of psychosis by mismatch negativity
Biol. Psychiatry
(2011) - et al.
Olfaction, “olfiction,” and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity
Schizophr. Res.
(2012) - et al.
Olfactory deficits, cognition and negative symptoms in early onset psychosis
Schizophr. Res.
(2005) - et al.
On knowing and judging smells: identification and hedonic judgment of odors in schizophrenia
Schizophr. Res.
(2006) Olfactory dysfunction and its measurement in the clinic
World J. Otorhinolaryngol. – Head & Neck Surg.
(2015)- et al.
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function
Physiol. Behav.
(1984) - et al.
Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia
Schizophr. Res.
(2015) - et al.
Auditory P300 in individuals clinically at risk for psychosis
Int. J. Psychophysiol.
(2008) - et al.
Smell identification in individuals at clinical high risk for schizophrenia
Psychiatry Res.
(2014)
Further evidence for olfactory identification deficits in schizophrenia
Schizophr. Res.
Olfactory deficits in schizophrenia
Biol. Psychiatry
Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania Smell Identification Test
Neurosci. Res.
Olfactory sensitivity to androstenone in schizophrenic patients
Biol. Psychiatry
Child development risk factors for adult schizophrenia in the British 1946 birth cohort
Lancet
Identification of pleasant, neutral, and unpleasant odors in schizophrenia
Psychiatry Res.
The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth
J. Psychiatr. Res.
Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection
Int. J. Psychophysiol.
Olfactory deficits in neuroleptic naive patients with schizophrenia
Schizophr. Res.
Impact of psychiatric comorbidity in individuals at ultra high risk of psychosis - findings from the longitudinal youth at risk study (LYRIKS)
Schizophr. Res.
Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome
Schizophr. Res.
Olfactory dysfunction in schizophrenia: a qualitative and quantitative review
Neuropsychopharmacology
The prodromal phase of psychosis
Curr. Opin. Neurobiol.
Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments
NeuroImage
Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia
Schizophr. Res.
Olfactory sense in psychoses
Biol. Psychiatry
Olfactory physiological impairment in first-degree relatives of schizophrenia patients
Schizophr. Res.
Olfaction and schizophrenia clinical risk status: just the facts
Schizophr. Res.
Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode
Biol. Psychiatry
Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence
Schizophr. Res.
Olfactory memory in unmedicated schizophrenics
Schizophr. Res.
Altered G protein coupling in olfactory neuroepithelial cells from patients with schizophrenia
Schizophr. Bull.
Cited by (12)
Pleasant and unpleasant odor identification ability is associated with distinct dimensions of negative symptoms transdiagnostically in psychotic disorders
2022, Schizophrenia ResearchCitation Excerpt :Demonstration of such predictive utility would further support the use of olfaction as a method to identify specific preferential clinical targets. Promising past work has again shown preliminary utility in using olfaction as a longitudinal predictor, for example showing that pleasant (but not unpleasant) odor identification impairment is associated with increased odds of conversion to psychosis in an at-risk sample (Kotlicka-Antczak et al., 2017), and that poor olfactory identification performance generally predicts longitudinal persistence of negative symptoms measured univariately (Good et al., 2006). Our findings suggest that better-powered samples and a more fine-grained assessment of symptoms may enable greater predictive utility in the clinical domains assessed in this past work.
Olfactory dysfunction and face processing of social cognition in first-episode psychosis
2022, Neuroscience ResearchOlfactory and cognitive functions in Chinese individuals at clinical high risk for psychosis
2019, Psychiatry ResearchCitation Excerpt :There are several studies that have reported the olfactory deficits in schizophrenia patients (SZs and those at clinical high risk for psychosis (CHRs) (Kotlicka-Antczak et al., 2017; Lin et al., 2015; Moberg et al., 2014; Takahashi et al., 2017). Some studies have outcome data and have found CHRs with later psychosis onset tend to have worse olfactory functions, though the results are inconsistent (Brewer et al., 2003; Kotlicka-Antczak et al., 2017; Lin et al., 2015; Woodberry et al., 2010). However, olfactory function is highly correlated with culture (Kobayashi et al., 2006) and most of these studies were either focused on populations in the West or used tests that were developed for those in the West such as the UPSIT (University of Pennsylvania Smell Identification Test) (Doty et al., 1984) and the Sniffin's Sticks test (Hummel et al., 1997).
Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders
2023, Journal of Neuroscience